about
Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expressionHighly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentRestoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells.Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interactionCombination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung CancerPatient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells.Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.Diadenosines as FHIT-ness instructors.Comprehensive genomic profiles of small cell lung cancer.Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.Quantification of free circulating DNA as a diagnostic marker in lung cancer.Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cellsKAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.Adipose tissue displays trophic properties on normal lung cellular components without promoting cancer cells growth.Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines.EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.Detecting lung cancer in plasma with the use of multiple genetic markers.Identification of PTEN-related sequences in glioma cells and in non-neoplastic cell lines.Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.Smoking out the cholinergic component in lung cancer.FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.Complement C4d-specific antibodies for the diagnosis of lung cancer.Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.
P50
Q24643042-491F2DD4-9E49-46F7-98DC-BAAA717F9FF8Q24656967-AD524A4C-CF22-4A64-82B3-B0ABEF697F75Q34019362-864EA204-59FA-47A0-9D23-BF4DF41005BBQ34621552-11C0A27A-6554-4B06-903D-6F8B12D81A05Q35060289-7ED2886C-5C09-4F28-8450-1398DEEB8C3EQ35679203-064B5382-5E4E-4891-9552-460691E5BEE0Q35744111-E844D972-D2FD-4736-8FD0-8DA2FAA0BEA5Q35884941-520C9331-6222-4F8C-937D-B551AE9810AAQ36038692-08B02302-6C3E-4C75-805A-AD2AD4E723C2Q36425640-55049517-4DFB-49C2-9596-F560FCF0FEE1Q36883530-968BCC37-4029-452D-BFF6-1E6D73CC8B80Q36925169-6BB1BDF3-3BF1-4660-A190-F6D3579D22DFQ37696123-566A81AF-4B17-40C2-BE29-8B0B3AF040C9Q38273474-5F43BB00-2404-4A31-A098-E15354578A51Q38350044-9B95EDF2-E468-4F30-B9A4-7F6657B31E08Q38576565-6F3CDF07-54B0-44FF-9557-0250B7BE8850Q38739226-348B70A3-DF35-4599-BF7A-14FE4317C816Q38823872-F2C92DF8-9D11-4E8D-A7EC-CD6A38321FB5Q38849554-5638C044-77C6-4A56-8F89-54EDD2B791D3Q38856807-BDE58EC1-003A-431D-8949-9DB23705FC75Q38891774-80341ACE-D892-4193-8C60-BEC6727024A0Q39248958-21A719A3-2589-4521-9369-95183FCEF027Q39378243-E5B3A2B0-7BC5-4976-9269-C6453255F3E1Q39708447-799766AC-94E2-4743-82BA-0EB0127135B6Q39924350-DEE35AE0-754B-43AA-B6EF-648ED8A24A29Q40292316-F5665961-A12B-4822-8E95-69BB25C29BCDQ40423134-7E695A5E-97EB-4F75-BE1E-A2DF43949AA8Q40503168-71A8800F-08E3-46BF-91F2-7A7BED1F2932Q40516572-42C40ADB-D1E1-4BBB-87F7-98B32B21602BQ41158938-4E59346F-7715-4CCD-A133-C253F7BF50BCQ44656374-2143CCDE-4BA2-422E-B0E6-9E5066316C24Q45858964-B5CC3DFB-63FC-4E1E-8E95-0EB697FE4A54Q46190550-1B570AA4-F62D-48AF-85B5-38E47DACF52AQ46267087-98DD0B90-ECB5-47D4-81E3-D355DA1542DCQ46437964-3E145BFE-7A5C-46EC-B0E2-F11EB458307EQ46694347-0F7032EF-D293-4689-AD16-47ACB0D25F0DQ49787484-504C8892-CE66-403C-8CB0-1AC2595C7263Q51095916-495FFF69-0277-4885-8B31-25633E04E2F4Q51122492-E9BA2998-DE38-4827-89A6-7B51681693FBQ51763437-7A0D111A-5526-4588-A22C-599440711512
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luca Roz
@ast
Luca Roz
@en
Luca Roz
@es
Luca Roz
@nl
Luca Roz
@sl
type
label
Luca Roz
@ast
Luca Roz
@en
Luca Roz
@es
Luca Roz
@nl
Luca Roz
@sl
prefLabel
Luca Roz
@ast
Luca Roz
@en
Luca Roz
@es
Luca Roz
@nl
Luca Roz
@sl
P106
P1153
6603415791
P21
P31
P496
0000-0001-5817-7149